Home / Eptifibatide / Czechia
CZ ATC B01AC16 · updated 2 Nov 2026
Eptifibatide shortage in Czechia
Is there an Eptifibatide shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Eptifibatide product is reported short in Czechia, the first since 19 Oct 2026. The company estimate for the return is 30 Nov 2026. Main reason: manufacturing problem.
Also short in Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | EPTIFIBATIDE ACCORD 2MG/ML 2MG/ML INJ SOL 1X10ML | Accord Healthcare S.L.U., Barcelona | 19 Oct 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.